Analyst Coverage Initiated: PRCT rating Buy by B. Riley Securities
Price Target: $53
Report Date: 06-23-2022
Symbol: PRCT - PROCEPT BioRobotics Corporation
Sector: Healthcare
Industry: Medical Devices
Analyst Coverage Initiated: PRCT rating Buy by B. Riley Securities
Price Target: $53
PROCEPT BioRobotics Corporation (PRCT)
900 Island Drive
Redwood City, CA
Phone: 650 232 7200
Website: http://www.procept-biorobotics.com
CEO:
NASDAQ, Nasdaq Global Market
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is based in Redwood City, California.
free stock trading signals, free trading signals, free stock market signals, free stock signals
Good stock signals have been found on this server. That is all we know.
+1 (407) 559-7228